Tuberculosis is a daunting problem that disproportionately affects those living in poverty, and it is the leading cause of death from infectious disease worldwide.
In 2016, an estimated 10.4 million new cases were reported – nearly 1 million of these were children living in the poorest countries – and nearly 1.7 million people died from the disease.
The current drugs take too long to work, have many side effects, are very costly, and there is also a growing urgency due to numerous strains resistant to current medications. New medicines are desperately needed.
Lgenia exists to find hope for these problems. Lgenia believes that new medicines begin their trek to patients right at the very start of discovery. The very best, highest quality medicines should be affordable and accessible to all patients. A new future begins with Lgenia – the essence of lead generation…
Lgenia's mission is to discover new medications for debilitating diseases and make them affordable to all.See more